Strategic planning

As the demand for health-economic data has increased, program planning requirements have become more complex. Needs for pharmacoeconomic and pharmacoepidemiologic data must be identified during clinical development, and studies must be planned not only during Phase II and III clinical trials but also following product launch. PAI has assisted numerous companies in the design of multifaceted pharmacoeconomic programs to address marketplace needs for health-economics data.